Short answer · Medically reviewed summary · Last updated: 2026-05-08
Androgen Insensitivity Syndrome (AIS) management focuses on personalized care, including hormone replacement therapy, surgical consultation for gonad management, and specialized psychological support. Because Androgen Insensitivity Syndrome presents along a spectrum—ranging from Complete (CAIS) to Partial (PAIS)—treatment must be tailored to the individual’s specific phenotype and clinical needs. What are the primary treatment approaches for Androgen Insensitivity Syndrome? Treatment for Androgen Insensitivity Syndrome is multidisciplinary and must be individualized.
Androgen Insensitivity Syndrome (AIS) management focuses on personalized care, including hormone replacement therapy, surgical consultation for gonad management, and specialized psychological support. Because Androgen Insensitivity Syndrome presents along a spectrum—ranging from Complete (CAIS) to Partial (PAIS)—treatment must be tailored to the individual’s specific phenotype and clinical needs.
Treatment for Androgen Insensitivity Syndrome is multidisciplinary and must be individualized. For individuals with CAIS, the primary focus is typically estrogen replacement therapy (ERT) to promote bone health and prevent symptoms of menopause after gonadectomy. In cases of PAIS, treatment may involve more complex hormonal management and, in some instances, surgical interventions to address genital ambiguity or functional concerns, always conducted with deep sensitivity to patient autonomy.
Managing Androgen Insensitivity Syndrome requires a coordinated team to address physical and emotional health. A comprehensive care team typically includes:
Non-pharmacological care is vital for those living with Androgen Insensitivity Syndrome. This may include pelvic floor physical therapy or the use of vaginal dilators to address vaginal hypoplasia. Surgical decisions regarding the timing of gonadectomy—often delayed until after puberty to allow for natural growth—are complex and require shared decision-making between the patient and their clinical team to balance cancer risk with hormonal development.
Effectiveness varies significantly based on the degree of androgen receptor function. While Androgen Insensitivity Syndrome is classified by these degrees, every patient's experience is unique. Currently, there are no curative pharmacological treatments for the underlying genetic mutation; therefore, care focuses on quality of life and long-term health maintenance.
Medical disclaimer: This content is for informational purposes only and does not replace professional medical advice; please consult your healthcare provider for personalized treatment decisions.